Related Experiment Video
Updated: Jul 5, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Attenuated neuropathic pain in Cav3.1 null mice
Heung Sik Na1, Soonwook Choi, Junesun Kim
1Center for Neural Science, Korea Institute of Science and Technology, Seoul 136-791, Korea.
Molecules and Cells
|April 17, 2008
Summary
Alpha-1G T-type calcium channels are crucial for neuropathic pain development. Mice lacking these channels showed reduced pain responses, suggesting they are a potential therapeutic target for allodynia and hyperalgesia.
Area of Science:
- Neuroscience
- Pain Research
- Ion Channel Physiology
Background:
- Neuropathic pain is a debilitating condition often associated with nerve injury.
- T-type calcium channels, particularly the alpha-1G (CaV3.1) subtype, are implicated in pain signaling pathways.
- Understanding the specific role of alpha-1G channels in neuropathic pain is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the contribution of alpha-1G T-type calcium channels to the development of neuropathic pain.
- To assess the behavioral pain responses in mice lacking the CaV3.1 gene.
Main Methods:
- Utilized a mouse model of neuropathic pain induced by L5 spinal nerve ligation.
- Examined behavioral pain susceptibility in wild-type and alpha1G(-/-) knockout mice.
- Assessed responses to mechanical stimuli, spontaneous pain, and thermal hyperalgesia using infrared stimulation.
Main Results:
- Mice lacking alpha-1G T-type calcium channels (alpha1G(-/-)) exhibited reduced spontaneous pain responses.
- An increased mechanical withdrawal threshold was observed in alpha1G(-/-) mice.
- Attenuated thermal hyperalgesia was noted in knockout mice following both low- and high-intensity infrared stimulation.
Conclusions:
- Alpha-1G T-type calcium channels play a significant role in the development and maintenance of neuropathic pain.
- Selective modulation of alpha-1G channels presents a potential novel therapeutic strategy for treating allodynia and hyperalgesia.
- These findings highlight the therapeutic potential of targeting specific T-type calcium channel subtypes for pain management.
